HHS invests nearly $600 million in Moderna’s bird flu vaccine development
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.
The American Journal of Managed Care51m
New Insights Into H5N1 Variability in Human Mutations
Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical ...
US awards Moderna $590 million for bird flu vaccine development
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...